Full-Time

Senior Imaging Science Engineer

Confirmed live in the last 24 hours

Calyxo

Calyxo

51-200 employees

Develops medical devices for kidney stone treatment

Compensation Overview

$160k - $198k/yr

+ Stock Options + Employee Benefits Package

Senior

No H1B Sponsorship

Pleasanton, CA, USA

Work location: Pleasanton (Rosewood) - on-site 5 days a week

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Python
SolidWorks
Requirements
  • MS in Imaging Science, Optical Engineering, Electrical Engineering, Physics or a related technical field. PhD preferred and 4+ years of experience in product development related to camera and illumination system design/characterization.
  • Deep technical expertise in camera and illumination system quantitative analysis, including relevant standards (e.g. ISO 8600, 12233, 14524 and 15739) and colorimetry, including practical application of CIE ΔE and ΔC measurement.
  • Practical experience in hands-on laboratory optics, including use of optical test targets, backlights, optomechanics, meters, sensors and other test equipment.
  • Experience performing photometric and radiometric quantitative analyses of illumination systems, including power meters, spectroradiometers and spectrophotometers.
  • Practical working knowledge of analog and digital electronics fundamentals.
  • Experience using Imatest software for image quality assessment.
  • Proficiency in Python or alternative scripting language for image/video analysis, hardware control and test automation strongly preferred.
  • Expertise in optical/optomechanical component and system design. ZEMAX (or alternative ray-tracing software) and SolidWorks (or alternative CAD software) preferred.
  • Experience leading external vendors and contract manufacturers in the development of custom imaging solutions.
  • Strong problem-solving skills and experience working as part of multifunctional technical project teams through all development lifecycle phases.
  • Experience in requirements definition, design reviews, change management and risk control.
  • Excellent technical writing and verbal communication skills are a must.
  • Ability to work independently or in a team setting required.
  • Must be self-directed, self-motivated and be able to multi-task in a fast-paced environment with multiple priorities.
  • Knowledge and ability to interpret and follow applicable regulations, guidelines, and policy statements is required. Must have experience working under quality systems designed to meet governmental regulations such as FDA QSR, ISO 13485, and the MDD.
  • Ability to travel domestically and internationally up to 10% of the time.
Responsibilities
  • Design camera and illumination optical systems/sub-systems for endoscopy and perform detailed quantitative analyses of their imaging & video performance.
  • Work with cross-functional teams to define requirements for image and video quality.
  • Drive in-process and end-of-line optical test methodology used in component and device manufacturing.
  • Work with clinical engineering and product management to translate user feedback on visualization quality into bench-testable design improvements.
  • Organize design reviews to ensure optimal imaging design performance across disposable instruments, capital hardware, and software interfaces.
  • Create change orders, test protocols/reports and design documents.
  • Complete Design Verification testing and risk management activities.
  • Interact with suppliers and internal operations representatives to perform root cause investigation, component lifecycle management and continuous improvement.
  • Create, operate and maintain an optical test bench and testing laboratory environment complying with Calyxo’s internal Quality Management System.
  • Contribute to the technology roadmap for visualization and related research endeavors.
  • Contribute to a culture of continuous improvement and innovation among engineering and cross-functional teams.
  • Collaborate with cross-functional teams to bring prototypes to the market.
  • Mentor junior and non-specialist engineering talent, promoting a collaborative and high-performance work environment.
Desired Qualifications
  • Experience and involvement with MDRs, IDEs, and 510(k) filings is preferred.

Calyxo develops medical devices specifically designed to treat kidney stones. Their products focus on improving the effectiveness and safety of treatment options available to urologists. By collaborating with leading urologists, Calyxo ensures that their devices meet the real clinical needs of healthcare providers. Unlike many competitors, Calyxo emphasizes a strong partnership with medical professionals to enhance patient care and clinical outcomes. The company's goal is to provide advanced solutions that make kidney stone treatment more efficient and effective, ultimately improving the overall experience for both patients and healthcare providers.

Company Size

51-200

Company Stage

Series D

Total Funding

$97.2M

Headquarters

Pleasanton, California

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA clearance for the redesigned CVAC System boosts market credibility and adoption.
  • Rising prevalence of kidney stones expands Calyxo's potential customer base.
  • Series D funding of $50M supports further innovation and market expansion.

What critics are saying

  • Emerging competition may impact Calyxo's market share in kidney stone treatments.
  • Economic downturns could reduce healthcare spending on new medical devices.
  • Rapid technological advancements require Calyxo to continuously innovate to stay competitive.

What makes Calyxo unique

  • Calyxo's CVAC System offers superior stone clearance compared to standard URS.
  • The company focuses on minimally invasive kidney stone treatments with high patient satisfaction.
  • Calyxo collaborates with leading urologists to enhance R&D and device innovation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Stock Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

-7%
Business Wire
May 14th, 2024
Study Presented At Aua Shows Superior Kidney Stone Clearance Rates For Sure Procedure Using Calyxo’S Cvac System Vs Standard Urs

PLEASANTON, Calif.--(BUSINESS WIRE)--Calyxo, Inc., a medical device company developing innovative solutions for patients with kidney stones, has announced that positive study results for its CVAC System were presented last week at the American Urological Association (AUA) Annual Meeting in San Antonio. The CVAC System, a revolutionary technology that is designed for complete kidney stone removal, was the focus of the prospective, randomized, multi-center ASPIRE study, which compared the safety and efficacy of steerable ureteroscopic renal evacuation (SURE) vs ureteroscopy (URS) with basketing. The 30-day results of the ASPIRE study were presented at the AUA Meeting by urologist Thomas Chi, MD of the University of California, San Francisco. In 101 patients, SURE demonstrated statistically superior stone clearance and significantly lower residual stone volume compared to standard URS. Unlike standard URS, the CVAC System achieved these results independent of baseline stone burden. Safety was comparable between groups

Business Wire
Mar 26th, 2024
Calyxo Announces Fda Clearance For New, Redesigned Cvac System

PLEASANTON, Calif.--(BUSINESS WIRE)--Calyxo, Inc., a medical device company developing innovative solutions for patients with kidney stones, announced that it has received FDA clearance for its new, redesigned CVAC System, which enables a minimally invasive approach to kidney stone treatment. More than 50 procedures have already been completed by 12 urologists with the new CVAC System, yielding strong patient outcomes and consistently positive physician feedback. Clinical studies have shown that residual stone fragments are associated with a 20%-44% incidence of post-procedure problems, including pain, infection, emergency department visits, hospitalization and need for retreatment. Steerable ureteroscopic renal evacuation (SURE) using the original CVAC Aspiration System has been used to successfully treat more than 1,500 patients in the U.S., demonstrating that vacuum aspiration of stone fragments improves clinical outcomes, with 97% volumetric stone clearance and a high likelihood of avoiding the need for a secondary or more invasive procedure (according to clinical study data collected in patients treated with the device)

Finsmes
Dec 12th, 2023
Calyxo Raises $50M in Series D Funding

Calyxo, a Pleasanton, CA-based medical device company developing next-generation treatment solutions for patients with kidney stones, raised $50M in Series D funding.

Questa Capital
Jul 6th, 2022
Questa Capital invests into Calyxoinc in $32.7M

Calyxo, Inc., a medical device company focused on improving care for patients with kidney stones by delivering next generation treatment solutions, has announced the closing of a $32.7 million Series C financing round led by Questa Capital and CRG.

Business Wire
Jul 6th, 2022
Calyxo Raises $32.7 Million In Series C Financing To Support Novel Approach To Treating Kidney Stones

PLEASANTON, Calif.--(BUSINESS WIRE)--Calyxo, Inc., a medical device company focused on improving care for patients with kidney stones by delivering next generation treatment solutions, has announced the closing of a $32.7 million Series C financing round led by Questa Capital and CRG. Calyxo has developed the innovative CVAC Aspiration System that utilizes irrigation and aspiration to remove kidney stones with the goal of a surgically stone-free outcome, a challenge that has always been difficult to achieve consistently